• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Industrials·300430.SZ
Share

Beijing Chieftain Control Technology Group Co., Ltd. Stocks

CN¥ 4.59Last Updated 10.07.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

CN¥ 184.87M

CN¥ 4.59
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly undervalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Beijing Chieftain Control Engineering Technology Co., Ltd. (BCCET), established in Beijing, China in 2003, specializes in the development, manufacturing, and sales of advanced automation systems for industrial production processes. The company primarily caters to the biological and pharmaceutical sectors within China. BCCET offers an extensive range of equipment, notably for powder processing, which includes dust-free crushing and pulse air mixing systems, automated lifting hopper mixers, dust-free feeding stations, ton bag unloaders, vacuum conveying solutions, precise metering and packing machines, CIP cleaning units, and auxiliary equipment such as dry granulators. Furthermore, their portfolio features sophisticated aseptic isolation technology, encompassing sterile isolation systems for packing and batching, restricted access barriers, negative pressure isolation units for operating environments, and reactor isolation feeding systems. The company also provides gas chloride sterilization apparatus and intelligent packing machinery. Beyond these, BCCET supplies a comprehensive array of specialized pharmaceutical and chemical equipment, covering processes like Chinese medicine extraction, evaporation concentration, purification and separation, fermentation preparation, distillation, and drying. Complementing their machinery, they also produce high-performance components such as diaphragm valves, globe valves, diaphragm globe valves, and other biomedical products, alongside professional medical pumps. These advanced solutions are widely applied across diverse industries, including pharmaceuticals, chemicals, food processing, additive manufacturing, power generation, and other industrial fields.

Company Valuation

Greatly undervalued
7/7

Based on key historical and expected multiples, the stock is greatly undervalued relative to its peers. In particular, the stock is underpriced on P/E.

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

12.07.2026 05:26

The U.S. announced a third wave of strikes against Iran following the closure of the Strait of Hormuz

11.07.2026 19:01

A Triumph for City Governments? How China’s Scaling Model Will Change the Global AI Market

11.07.2026 16:01

Highlights from Small-Caps: Royce Fund Forecast, Trump's Sons' Investments, the Chewy Case Study

11.07.2026 15:32

SK Hynix's Record-Breaking IPO: What's Behind the Hype Surrounding Memory Chip Manufacturers

11.07.2026 13:01

Where Holann Is Investing, AI to Focus on Pharmaceuticals, and SK Hynix's Record-Breaking Offering

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026